About this document

Betamethasone Dose Reduction in Neonates by Génesis Minerva is a document available to read on EtoBox.

This study investigates the impact of antenatal betamethasone dose reduction on survival without severe neonatal morbidity in very preterm infants, comparing half-dose and full-dose regimens. The results indicate no significant differences in survival rates or cumulative neonatal morbidities between the two groups. The findings suggest that a reduction in betamethasone dosage may be safe, but further research is needed to assess long-term neurodevelopmental outcomes.

Author

Génesis Minerva

Language

EN